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Living organisms must deal with environmental toxins, metabolic waste products, and, primarily in humans, drugs with extremely diverse structures in order to remain viable.
In mammals, these toxic organic compounds are mainly excreted through the kidney and liver. Renal excretion involves glomerular filtration and/or tubular secretion. Toxic organic compounds are taken up at the basolateral membranes of tubule cells, followed by excretion out of the cells at the brush-border membranes (1) (2) (3) (4) (5) (6) (7) . Hepatocytes also absorb toxic organic compounds at the sinusoidal membranes and excrete them through the bile canaliculi (1) (2) (3) (4) (5) (6) (7) . Although it has been concluded from a large number of biochemical and physiological studies that a transporter(s) is principally responsible for the final step of excretion of organic cations (OCs), its molecular identity remains unknown (5-7). The putative OC exporter mediates electroneutral H + /OCs exchange (5-7). Furthermore, it recognizes a wide variety of OCs including cationic drugs, some vitamins and many endogenous compounds such as choline and dopamine and, thus, should be regarded as a multidrug or polyspecific exporter (5-7). We, therefore, hypothesized that mammalian orthologue(s) of bacterial multidrug transporters, if any, are responsible for the extrusion of OCs.
Bacterial multidrug transporters have been classified into several groups, which include the major facilitator superfamily (MSF), the small multidrug resistance (SMR) family, the resistance nodulation cell division (RND) family, the ATP binding cassette (ABC) family, and MATE family (8) (9) (10) . Of them, MATE family is the most recently classified multidrug resistance-conferring protein family (8) (9) (10) . Although the overall properties of the MATE family are not elucidated yet, some MATE-type proteins mediate H + -or Na + -coupled export of cationic drugs in bacteria (8) (9) (10) .
In the present study, we identify human and mouse MATE orthologues, MATE1 and MATE2. We present evidence that MATE1 is predominantly expressed in kidney and liver and responsible for the final step of excretion of organic cations (OCs) through exchange of protons. Western blot analysis. Human tissue samples were obtained from CosmoBio.
Total membrane fractions of mouse (ddY) tissues (about 1 g wet weight each) were isolated, suspended in 20 mM MOPS-Tris, pH. 7.0, 0.3 M sucrose, 5 mM EDTA, and protease inhibitors (pepstatin A, leupeptin, antipain, and chymostatin at 10 µg/ml each), and then homogenized. The postnuclear supernatant was centrifuged at 100,000 x g for 1 h, and the pellet was suspended in the same buffer and used as a protein sample after denaturation with buffer containing 1% SDS and 10% β-mercaptoethanol. Samples (100 µg protein for human and 200 µg protein for mouse) were subjected to electrophoresis; Western blotting was performed subsequently as described (12) .
Immunohistochemistry. Human paraffin tissue sections were obtained from Biochain. Immunohistochemical analysis was performed by the HRP-DAB method or indirect immunofluorescence microscopy as described (12) . The primary antibody treatment was performed at a concentration of 1 µg/ml or diluted x1000 in phosphate-buffered saline (PBS) containing 0.5% bovine serum albumin for 1 h at room temperature. Specimens were then examined under either an Olympus BX60 microscope or an Olympus FV300 confocal laser microscope.
Immunoelectron microscopy. The pre-embedding silver enhancement immunogold method was used as described (12) . Mice (ddY) were anesthetized with ether and then perfused intracardially with saline, followed by 4 % paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The kidneys were isolated and washed with PBS.
The organs were successively infiltrated with 30% sucrose in PBS, embedded in OTC compound (Sakura FineTek), sectioned at 6 mm thickness, and then mounted on (PerkinElmer Life Science, Inc.) as described (13) . At appropriate times, aliquots of the mixture (200 µl) were filtered through 0.45 µm HA membrane filters (Millipore).
Each filter was washed with ice-cold the medium and the radioactivity remaining on the filter was counted.
Results and Discussion
Gene organization and expression of human MATEs. We searched for mammalian orthologues of bacterial MATE-type multidrug transporters in genomic databases.
Upon screening the entire working draft of the human genome database, we found two genes encoding orthologues of bacterial MATE family. The genes are located in tandem on chromosome 17, and the gene products are designated hMATE1 (accession number, NP-060712) and hMATE2 (accession number, NP-690872) (Fig. 1) . The deduced amino acid sequences of hMATE1 and hMATE2 exhibit 19.8 and 18.6% 8 identity to that of the NorM Na + /multidrug antiporter in Vibrio parahaemolyticus, a prototype of the MATE family (14) (Fig. 2A) . A hydropathy plot of hMATE1 predicts 12 transmembrane domains (Fig. 2B) . Northern blot analysis of human tissues revealed that the gene encoding hMATE1 is primarily expressed in kidney, liver and skeletal muscle as a 4.1 kilobase (kb) transcript. The expression in the other organs examined was below the detection limit (Fig. 3) . In contrast, the gene encoding hMATE2 is expressed as a 3.2 kb transcript in skeletal muscle, but not in kidney or liver (Fig. 3) .
Renal and hepatic localization of hMATE1. We attempted to determine the expression and localization of hMATE1 as a candidate H + -coupled OC exporter at the protein level. In Western blot analysis, site-specific polyclonal antibodies against the carboxyl terminal region of hMATE1 revealed the broad immunoreactive protein band of the expected size (~62 kDa) in human kidney membranes (Fig. 4A) . The preabsorbed antibodies did not yield the immunoreactivity (Fig. 4A ). Horseradish peroxidase (HRP)-DAB staining of human tissues showed that the antibodies predominantly immunostained the apical regions of the proximal and distal convoluted tubules of the kidney (Fig. 4B ) and bile canaliculi (Fig. 4C, arrows) .
Expression and localization of mMATE1. Because of the limited availability and quality of human samples for studies on the subcellular localization of MATE1, we investigated mouse homologues. Genes encoding mouse homologues are located in tandem on chromosome 11 and the gene products are designated mMATE1 (accession number, AAH31436) and mMATE2 (accession number, XP_354611) (supplemental information, Fig. S1 ). Their deduced amino acid sequences are 78.1 and 38.1%
identical to that of their human counterparts, respectively (supplemental information, Fig.   S2 ). Northern blot analysis showed that gene encoding mMATE1 was predominantly expressed in kidney, liver and heart as a 3.8 kb transcript, while that of mMATE2 was specifically expressed in testis as a 3.3 kb transcript (Fig. 5A) . In Western blot analysis, site-specific polyclonal antibodies for mMATE1 recognized a single polypeptide of about 53 kDa in the membranes of the kidney and liver, but the levels were low or below the detection limit in the other organs examined (Fig. 5B) . The HRP-DAB staining of a mouse kidney specimen revealed strong immunoreactivity in the apical region of cortical collecting ducts, proximal convoluted tubules (Fig. 5Ca) , and thin limb of Henle's loop (Fig. 5Cb) . Lower but distinct immunoreactivity was also observed in the distal convoluted tubules and glomerulus (Fig. 5Ca) . The localization of mMATE1 in the brush border membrane of proximal tubules was demonstrated by immunoelectron microscopy (Fig. 5D ). In the liver, mMATE1 is localized to the bile canaliculi ( Fig.   5E ) and the apical region of the bile duct (Fig. 5F) . Together, these results demonstrated that MATE1 is predominantly found in the kidney and liver and is localized to the renal brush-border membrane and bile canaliculi, which agrees with that of H + /OC exchange activity (5-7).
MATE1 mediates a H + -coupled electroneutral OC exchange.
To answer the question whether MATE1 exhibits H + -coupled OC transport, we measured the pH-dependent translocation of OCs across the plasma membranes of hMATE1-expressing HEK293 cells. This approach allowed us to study the luminal efflux of OCs as a classical cellular uptake (13) . Upon expression of hMATE1, the protein predominantly localized at the plasma membrane region (Fig. 6A) . Some immunoractivity was also observed in the internal organelles. The hMATE1-expressing cells exhibited time-dependent transport activity towards tetraethylammonium (TEA), a typical substrate for the H + -coupled OC exporter (2,15), while MOCK control cells did not (Fig. 6B) . Around 10 % mutated hMATE1 with the amino acid replacement E273Q (Glu273 to Gln), the counterpart of an essential amino acid residue found in the bacterial NorM protein (16), also predominantly localized at the plasma membrane region but lacked detectable MATE1-dependent TEA transport activity (Fig. 6A, B) . The transport activity of the wild type was saturable, with a K m value for TEA of 220 µM (Fig. 6C) . The transport also showed pH dependence: the transport activity was lower at pH 6.0, increased at higher extracellular pH, and became maximal at around pH 8.0 -8.5 (Fig. 6D) . Na + was not required for transport activity (Fig. 6E ). The addition of 5 µM valinomycin in the presence of 65 mM KCl, which causes membrane depolarization, did not affect the TEA uptake, whereas 10 mM ammonium chloride inhibited the uptake by 60%. In addition, 10 µM SF6847, a proton conductor, and 5 µM nigericin in the presence of KCl, which dissipates the pH gradient, decreased the uptake to the level of MOCK control (Fig. 6E) . Furthermore, TEA taken up by the cells was released upon an acute decrease in extracellular pH to 6.0 by means of acid pulse (Fig. 6F) . Together, these results indicated that hMATE1 mediated electroneutral H + /TEA exchange. The pharmacology of the cis-inhibition of TEA transport was similar to that of renal H + -coupled OC export (1-7): it is strongly inhibited by cimetidine, quinidine or verapamil, less so by nicotine or choline, but not at all by organic anions such as p-aminohippurate (PAH) and uric acid (Table 1) . Similar pH-dependent transport was observed for MPP, another well-known substrate of the H + -coupled OC export (5); the K m and V max measured were 16 µM and 170 pmol/min/mg protein, respectively. Thus, MATE1 exhibited properties equivalent to those of the putative renal H + -coupled OC exporter.
MATE1 as a OC exporter at the final step of excretion. Based on this information, we conclude that MATE1 is the long searched for H + -coupled OC exporter that mediates the final step of excretion of OCs in kidney and liver (Fig. 7) .
Our findings contribute to the understanding of the transporters underlying the excretion of toxic OCs from the body: OCs are taken up by organic cation transporter 1 (OCT1) or OCT2 in the renal tubule cells and hepatocytes (4-7), and then excreted out of the cells through a co-operation between MATE1 and P-glycoprotein (Fig. 7) . The H + -coupled electroneutral transport should be important for permeation of OCs against potential difference across the plasma membrane. The cis-inhibition experiment suggested that MATE1 recognized various kinds of physiological metabolites, such as corticosterone, as transport substrates (Table 1) . Since MATE1 and MATE2 were expressed in organs other than kidney and liver (Figs. 3, 5A ), the function of mammalian MATE-type hMATE1-expressing cells were incubated with 50 µM radiolabeled TEA as in Fig. 2B for 10 min. Then, the cells were transferred to buffer with the indicated pH (time = 0) and incubated for a further 10 min and the remaining radioactivity then assayed. Error bars are the standard deviation of three samples. 
